Latest Ipsen Stories
-- Telotristat etiprate, a Phase 3 compound for the treatment of carcinoid syndrome PARIS and THE WOODLANDS, Texas, Oct.
PARIS, June 30, 2014 /PRNewswire/ -- Pharnext SAS announced today that Ipsen has joined its Board of Directors. Highlights
BARCELONA, Spain, February 26, 2014 /PRNewswire/ -- Top pharmaceutical company selects Veeva Vault in enterprise initiative to
- a meat pie that is usually eaten at Christmas in Quebec